cure after tonsillectomy Periodic clinical signs; persistent over years; no response to antibiotics; increased proinflammatory cytokine levels during flares; responsive to corticosteroids ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...
The purpose of this health advisory is to remind clinicians to consider testing for mosquito-borne arboviruses in patients presenting with unexplained flu-like symptoms, encephalitis, aseptic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback